Global Blood-based Cancer Screening Tests Supply, Demand and Key Producers, 2026-2032
The global Blood-based Cancer Screening Tests market size is expected to reach $ 16079 million by 2032, rising at a market growth of 19.7% CAGR during the forecast period (2026-2032).
Blood-based cancer screening tests use peripheral blood signals such as circulating free DNA, circulating tumor DNA, methylation patterns, protein biomarkers, fragmentomics or multi-omics features to identify early cancer risk in asymptomatic or high-risk populations. These tests may target a single cancer type or multiple cancers and emphasize minimally invasive sampling, adherence, early detection capability, management pathways for positive and negative results and clinical validation evidence. They are commonly used in health check-ups, hospital screening, public health programs and high-risk population follow-up. The average gross profit margin of this product is 55%.
The blood-based cancer screening market is being driven by demand for early cancer detection, upgrades to colorectal cancer screening tools and accumulating clinical evidence for multi-cancer early detection. Blood sampling offers high adherence and is suitable for health check-up centers, hospital outpatient settings and high-risk population management.
Major technical routes include cfDNA methylation, multi-omics modeling, ctDNA mutation detection and protein marker combinations. Key competitive factors are early-stage sensitivity, specificity, tissue-of-origin capability, validation cohort size and cost control. Blood-based colorectal cancer tests have one of the clearest commercialization paths, while multi-cancer early detection still requires more real-world evidence.
Market adoption is affected by regulatory approval, inclusion in clinical guidelines, payment systems and the cost of managing false positives. Future growth will depend on results from large prospective studies, reimbursement by public or commercial payers, lower testing costs and clear positioning alongside established screening pathways.
This report studies the global Blood-based Cancer Screening Tests demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood-based Cancer Screening Tests, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood-based Cancer Screening Tests that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Blood-based Cancer Screening Tests total market, 2021-2032, (USD Million)
Global Blood-based Cancer Screening Tests total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Blood-based Cancer Screening Tests total market, key domestic companies, and share, (USD Million)
Global Blood-based Cancer Screening Tests revenue by player, revenue and market share 2021-2026, (USD Million)
Global Blood-based Cancer Screening Tests total market by Type, CAGR, 2021-2032, (USD Million)
Global Blood-based Cancer Screening Tests total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Blood-based Cancer Screening Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GRAIL, Guardant Health, Exact Sciences, Freenome, Natera, Foresight Diagnostics, Burning Rock Biotech, Genetron Health, Singlera Genomics, Berry Oncology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Blood-based Cancer Screening Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Blood-based Cancer Screening Tests Market, By Region:
1. How big is the global Blood-based Cancer Screening Tests market?
2. What is the demand of the global Blood-based Cancer Screening Tests market?
3. What is the year over year growth of the global Blood-based Cancer Screening Tests market?
4. What is the total value of the global Blood-based Cancer Screening Tests market?
5. Who are the Major Players in the global Blood-based Cancer Screening Tests market?
6. What are the growth factors driving the market demand?
Blood-based cancer screening tests use peripheral blood signals such as circulating free DNA, circulating tumor DNA, methylation patterns, protein biomarkers, fragmentomics or multi-omics features to identify early cancer risk in asymptomatic or high-risk populations. These tests may target a single cancer type or multiple cancers and emphasize minimally invasive sampling, adherence, early detection capability, management pathways for positive and negative results and clinical validation evidence. They are commonly used in health check-ups, hospital screening, public health programs and high-risk population follow-up. The average gross profit margin of this product is 55%.
The blood-based cancer screening market is being driven by demand for early cancer detection, upgrades to colorectal cancer screening tools and accumulating clinical evidence for multi-cancer early detection. Blood sampling offers high adherence and is suitable for health check-up centers, hospital outpatient settings and high-risk population management.
Major technical routes include cfDNA methylation, multi-omics modeling, ctDNA mutation detection and protein marker combinations. Key competitive factors are early-stage sensitivity, specificity, tissue-of-origin capability, validation cohort size and cost control. Blood-based colorectal cancer tests have one of the clearest commercialization paths, while multi-cancer early detection still requires more real-world evidence.
Market adoption is affected by regulatory approval, inclusion in clinical guidelines, payment systems and the cost of managing false positives. Future growth will depend on results from large prospective studies, reimbursement by public or commercial payers, lower testing costs and clear positioning alongside established screening pathways.
This report studies the global Blood-based Cancer Screening Tests demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood-based Cancer Screening Tests, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood-based Cancer Screening Tests that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Blood-based Cancer Screening Tests total market, 2021-2032, (USD Million)
Global Blood-based Cancer Screening Tests total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Blood-based Cancer Screening Tests total market, key domestic companies, and share, (USD Million)
Global Blood-based Cancer Screening Tests revenue by player, revenue and market share 2021-2026, (USD Million)
Global Blood-based Cancer Screening Tests total market by Type, CAGR, 2021-2032, (USD Million)
Global Blood-based Cancer Screening Tests total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Blood-based Cancer Screening Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GRAIL, Guardant Health, Exact Sciences, Freenome, Natera, Foresight Diagnostics, Burning Rock Biotech, Genetron Health, Singlera Genomics, Berry Oncology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Blood-based Cancer Screening Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Blood-based Cancer Screening Tests Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single-cancer Screening
- Multi-cancer Early Detection
- Colorectal Cancer Screening
- Liver Cancer Screening
- Lung Cancer Screening
- Risk Stratification Test
- Other
- cfDNA Methylation
- ctDNA Mutation
- Fragmentomics
- Protein Biomarkers
- Multi-omics
- Exosome-based
- Other
- Laboratory-developed Test
- IVD Kit
- Sequencing-based
- PCR-based
- Immunoassay-based
- Other
- Health Check-up Centers
- Hospitals
- Independent Clinical Laboratories
- Other
- GRAIL
- Guardant Health
- Exact Sciences
- Freenome
- Natera
- Foresight Diagnostics
- Burning Rock Biotech
- Genetron Health
- Singlera Genomics
- Berry Oncology
- Helio Genomics
- Sysmex
1. How big is the global Blood-based Cancer Screening Tests market?
2. What is the demand of the global Blood-based Cancer Screening Tests market?
3. What is the year over year growth of the global Blood-based Cancer Screening Tests market?
4. What is the total value of the global Blood-based Cancer Screening Tests market?
5. Who are the Major Players in the global Blood-based Cancer Screening Tests market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Blood-based Cancer Screening Tests Introduction
1.2 World Blood-based Cancer Screening Tests Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Blood-based Cancer Screening Tests Total Market by Region (by Headquarter Location)
1.3.1 World Blood-based Cancer Screening Tests Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.3 China Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.4 Europe Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.5 Japan Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.6 South Korea Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.7 ASEAN Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.8 India Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood-based Cancer Screening Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.2 World Blood-based Cancer Screening Tests Consumption Value by Region
2.2.1 World Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026)
2.2.2 World Blood-based Cancer Screening Tests Consumption Value Forecast by Region (2027-2032)
2.3 United States Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.4 China Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.5 Europe Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.6 Japan Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.7 South Korea Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.8 ASEAN Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.9 India Blood-based Cancer Screening Tests Consumption Value (2021-2032)
3 WORLD BLOOD-BASED CANCER SCREENING TESTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Blood-based Cancer Screening Tests Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Blood-based Cancer Screening Tests Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Blood-based Cancer Screening Tests in 2025
3.2.3 Global Concentration Ratios (CR8) for Blood-based Cancer Screening Tests in 2025
3.3 Blood-based Cancer Screening Tests Company Evaluation Quadrant
3.4 Blood-based Cancer Screening Tests Market: Overall Company Footprint Analysis
3.4.1 Blood-based Cancer Screening Tests Market: Region Footprint
3.4.2 Blood-based Cancer Screening Tests Market: Company Product Type Footprint
3.4.3 Blood-based Cancer Screening Tests Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Blood-based Cancer Screening Tests Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Blood-based Cancer Screening Tests Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Blood-based Cancer Screening Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Blood-based Cancer Screening Tests Consumption Value Comparison
4.2.1 United States VS China: Blood-based Cancer Screening Tests Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Blood-based Cancer Screening Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Blood-based Cancer Screening Tests Companies and Market Share, 2021-2026
4.3.1 United States Based Blood-based Cancer Screening Tests Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026)
4.4 China Based Companies Blood-based Cancer Screening Tests Revenue and Market Share, 2021-2026
4.4.1 China Based Blood-based Cancer Screening Tests Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026)
4.5 Rest of World Based Blood-based Cancer Screening Tests Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Blood-based Cancer Screening Tests Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Blood-based Cancer Screening Tests Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Blood-based Cancer Screening Tests Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single-cancer Screening
5.2.2 Multi-cancer Early Detection
5.2.3 Colorectal Cancer Screening
5.2.4 Liver Cancer Screening
5.2.5 Lung Cancer Screening
5.2.6 Risk Stratification Test
5.2.7 Other
5.3 Market Segment by Type
5.3.1 World Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
5.3.2 World Blood-based Cancer Screening Tests Market Size by Type (2027-2032)
5.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BIOMARKER
6.1 World Blood-based Cancer Screening Tests Market Size Overview by Biomarker: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Biomarker
6.2.1 cfDNA Methylation
6.2.2 ctDNA Mutation
6.2.3 Fragmentomics
6.2.4 Protein Biomarkers
6.2.5 Multi-omics
6.2.6 Exosome-based
6.2.7 Other
6.3 Market Segment by Biomarker
6.3.1 World Blood-based Cancer Screening Tests Market Size by Biomarker (2021-2026)
6.3.2 World Blood-based Cancer Screening Tests Market Size by Biomarker (2027-2032)
6.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2027-2032)
7 MARKET ANALYSIS BY TEST FORMAT
7.1 World Blood-based Cancer Screening Tests Market Size Overview by Test Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Test Format
7.2.1 Laboratory-developed Test
7.2.2 IVD Kit
7.2.3 Sequencing-based
7.2.4 PCR-based
7.2.5 Immunoassay-based
7.2.6 Other
7.3 Market Segment by Test Format
7.3.1 World Blood-based Cancer Screening Tests Market Size by Test Format (2021-2026)
7.3.2 World Blood-based Cancer Screening Tests Market Size by Test Format (2027-2032)
7.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Blood-based Cancer Screening Tests Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Health Check-up Centers
8.2.2 Hospitals
8.2.3 Independent Clinical Laboratories
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
8.3.2 World Blood-based Cancer Screening Tests Market Size by Application (2027-2032)
8.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GRAIL
9.1.1 GRAIL Details
9.1.2 GRAIL Major Business
9.1.3 GRAIL Blood-based Cancer Screening Tests Product and Services
9.1.4 GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GRAIL Recent Developments/Updates
9.1.6 GRAIL Competitive Strengths & Weaknesses
9.2 Guardant Health
9.2.1 Guardant Health Details
9.2.2 Guardant Health Major Business
9.2.3 Guardant Health Blood-based Cancer Screening Tests Product and Services
9.2.4 Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Guardant Health Recent Developments/Updates
9.2.6 Guardant Health Competitive Strengths & Weaknesses
9.3 Exact Sciences
9.3.1 Exact Sciences Details
9.3.2 Exact Sciences Major Business
9.3.3 Exact Sciences Blood-based Cancer Screening Tests Product and Services
9.3.4 Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Exact Sciences Recent Developments/Updates
9.3.6 Exact Sciences Competitive Strengths & Weaknesses
9.4 Freenome
9.4.1 Freenome Details
9.4.2 Freenome Major Business
9.4.3 Freenome Blood-based Cancer Screening Tests Product and Services
9.4.4 Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Freenome Recent Developments/Updates
9.4.6 Freenome Competitive Strengths & Weaknesses
9.5 Natera
9.5.1 Natera Details
9.5.2 Natera Major Business
9.5.3 Natera Blood-based Cancer Screening Tests Product and Services
9.5.4 Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Natera Recent Developments/Updates
9.5.6 Natera Competitive Strengths & Weaknesses
9.6 Foresight Diagnostics
9.6.1 Foresight Diagnostics Details
9.6.2 Foresight Diagnostics Major Business
9.6.3 Foresight Diagnostics Blood-based Cancer Screening Tests Product and Services
9.6.4 Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Foresight Diagnostics Recent Developments/Updates
9.6.6 Foresight Diagnostics Competitive Strengths & Weaknesses
9.7 Burning Rock Biotech
9.7.1 Burning Rock Biotech Details
9.7.2 Burning Rock Biotech Major Business
9.7.3 Burning Rock Biotech Blood-based Cancer Screening Tests Product and Services
9.7.4 Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Burning Rock Biotech Recent Developments/Updates
9.7.6 Burning Rock Biotech Competitive Strengths & Weaknesses
9.8 Genetron Health
9.8.1 Genetron Health Details
9.8.2 Genetron Health Major Business
9.8.3 Genetron Health Blood-based Cancer Screening Tests Product and Services
9.8.4 Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Genetron Health Recent Developments/Updates
9.8.6 Genetron Health Competitive Strengths & Weaknesses
9.9 Singlera Genomics
9.9.1 Singlera Genomics Details
9.9.2 Singlera Genomics Major Business
9.9.3 Singlera Genomics Blood-based Cancer Screening Tests Product and Services
9.9.4 Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Singlera Genomics Recent Developments/Updates
9.9.6 Singlera Genomics Competitive Strengths & Weaknesses
9.10 Berry Oncology
9.10.1 Berry Oncology Details
9.10.2 Berry Oncology Major Business
9.10.3 Berry Oncology Blood-based Cancer Screening Tests Product and Services
9.10.4 Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Berry Oncology Recent Developments/Updates
9.10.6 Berry Oncology Competitive Strengths & Weaknesses
9.11 Helio Genomics
9.11.1 Helio Genomics Details
9.11.2 Helio Genomics Major Business
9.11.3 Helio Genomics Blood-based Cancer Screening Tests Product and Services
9.11.4 Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Helio Genomics Recent Developments/Updates
9.11.6 Helio Genomics Competitive Strengths & Weaknesses
9.12 Sysmex
9.12.1 Sysmex Details
9.12.2 Sysmex Major Business
9.12.3 Sysmex Blood-based Cancer Screening Tests Product and Services
9.12.4 Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sysmex Recent Developments/Updates
9.12.6 Sysmex Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Blood-based Cancer Screening Tests Industry Chain
10.2 Blood-based Cancer Screening Tests Upstream Analysis
10.3 Blood-based Cancer Screening Tests Midstream Analysis
10.4 Blood-based Cancer Screening Tests Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Blood-based Cancer Screening Tests Introduction
1.2 World Blood-based Cancer Screening Tests Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Blood-based Cancer Screening Tests Total Market by Region (by Headquarter Location)
1.3.1 World Blood-based Cancer Screening Tests Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.3 China Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.4 Europe Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.5 Japan Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.6 South Korea Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.7 ASEAN Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.3.8 India Based Company Blood-based Cancer Screening Tests Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood-based Cancer Screening Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.2 World Blood-based Cancer Screening Tests Consumption Value by Region
2.2.1 World Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026)
2.2.2 World Blood-based Cancer Screening Tests Consumption Value Forecast by Region (2027-2032)
2.3 United States Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.4 China Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.5 Europe Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.6 Japan Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.7 South Korea Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.8 ASEAN Blood-based Cancer Screening Tests Consumption Value (2021-2032)
2.9 India Blood-based Cancer Screening Tests Consumption Value (2021-2032)
3 WORLD BLOOD-BASED CANCER SCREENING TESTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Blood-based Cancer Screening Tests Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Blood-based Cancer Screening Tests Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Blood-based Cancer Screening Tests in 2025
3.2.3 Global Concentration Ratios (CR8) for Blood-based Cancer Screening Tests in 2025
3.3 Blood-based Cancer Screening Tests Company Evaluation Quadrant
3.4 Blood-based Cancer Screening Tests Market: Overall Company Footprint Analysis
3.4.1 Blood-based Cancer Screening Tests Market: Region Footprint
3.4.2 Blood-based Cancer Screening Tests Market: Company Product Type Footprint
3.4.3 Blood-based Cancer Screening Tests Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Blood-based Cancer Screening Tests Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Blood-based Cancer Screening Tests Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Blood-based Cancer Screening Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Blood-based Cancer Screening Tests Consumption Value Comparison
4.2.1 United States VS China: Blood-based Cancer Screening Tests Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Blood-based Cancer Screening Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Blood-based Cancer Screening Tests Companies and Market Share, 2021-2026
4.3.1 United States Based Blood-based Cancer Screening Tests Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026)
4.4 China Based Companies Blood-based Cancer Screening Tests Revenue and Market Share, 2021-2026
4.4.1 China Based Blood-based Cancer Screening Tests Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026)
4.5 Rest of World Based Blood-based Cancer Screening Tests Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Blood-based Cancer Screening Tests Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Blood-based Cancer Screening Tests Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Blood-based Cancer Screening Tests Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single-cancer Screening
5.2.2 Multi-cancer Early Detection
5.2.3 Colorectal Cancer Screening
5.2.4 Liver Cancer Screening
5.2.5 Lung Cancer Screening
5.2.6 Risk Stratification Test
5.2.7 Other
5.3 Market Segment by Type
5.3.1 World Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
5.3.2 World Blood-based Cancer Screening Tests Market Size by Type (2027-2032)
5.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BIOMARKER
6.1 World Blood-based Cancer Screening Tests Market Size Overview by Biomarker: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Biomarker
6.2.1 cfDNA Methylation
6.2.2 ctDNA Mutation
6.2.3 Fragmentomics
6.2.4 Protein Biomarkers
6.2.5 Multi-omics
6.2.6 Exosome-based
6.2.7 Other
6.3 Market Segment by Biomarker
6.3.1 World Blood-based Cancer Screening Tests Market Size by Biomarker (2021-2026)
6.3.2 World Blood-based Cancer Screening Tests Market Size by Biomarker (2027-2032)
6.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2027-2032)
7 MARKET ANALYSIS BY TEST FORMAT
7.1 World Blood-based Cancer Screening Tests Market Size Overview by Test Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Test Format
7.2.1 Laboratory-developed Test
7.2.2 IVD Kit
7.2.3 Sequencing-based
7.2.4 PCR-based
7.2.5 Immunoassay-based
7.2.6 Other
7.3 Market Segment by Test Format
7.3.1 World Blood-based Cancer Screening Tests Market Size by Test Format (2021-2026)
7.3.2 World Blood-based Cancer Screening Tests Market Size by Test Format (2027-2032)
7.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Blood-based Cancer Screening Tests Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Health Check-up Centers
8.2.2 Hospitals
8.2.3 Independent Clinical Laboratories
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
8.3.2 World Blood-based Cancer Screening Tests Market Size by Application (2027-2032)
8.3.3 World Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GRAIL
9.1.1 GRAIL Details
9.1.2 GRAIL Major Business
9.1.3 GRAIL Blood-based Cancer Screening Tests Product and Services
9.1.4 GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GRAIL Recent Developments/Updates
9.1.6 GRAIL Competitive Strengths & Weaknesses
9.2 Guardant Health
9.2.1 Guardant Health Details
9.2.2 Guardant Health Major Business
9.2.3 Guardant Health Blood-based Cancer Screening Tests Product and Services
9.2.4 Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Guardant Health Recent Developments/Updates
9.2.6 Guardant Health Competitive Strengths & Weaknesses
9.3 Exact Sciences
9.3.1 Exact Sciences Details
9.3.2 Exact Sciences Major Business
9.3.3 Exact Sciences Blood-based Cancer Screening Tests Product and Services
9.3.4 Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Exact Sciences Recent Developments/Updates
9.3.6 Exact Sciences Competitive Strengths & Weaknesses
9.4 Freenome
9.4.1 Freenome Details
9.4.2 Freenome Major Business
9.4.3 Freenome Blood-based Cancer Screening Tests Product and Services
9.4.4 Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Freenome Recent Developments/Updates
9.4.6 Freenome Competitive Strengths & Weaknesses
9.5 Natera
9.5.1 Natera Details
9.5.2 Natera Major Business
9.5.3 Natera Blood-based Cancer Screening Tests Product and Services
9.5.4 Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Natera Recent Developments/Updates
9.5.6 Natera Competitive Strengths & Weaknesses
9.6 Foresight Diagnostics
9.6.1 Foresight Diagnostics Details
9.6.2 Foresight Diagnostics Major Business
9.6.3 Foresight Diagnostics Blood-based Cancer Screening Tests Product and Services
9.6.4 Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Foresight Diagnostics Recent Developments/Updates
9.6.6 Foresight Diagnostics Competitive Strengths & Weaknesses
9.7 Burning Rock Biotech
9.7.1 Burning Rock Biotech Details
9.7.2 Burning Rock Biotech Major Business
9.7.3 Burning Rock Biotech Blood-based Cancer Screening Tests Product and Services
9.7.4 Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Burning Rock Biotech Recent Developments/Updates
9.7.6 Burning Rock Biotech Competitive Strengths & Weaknesses
9.8 Genetron Health
9.8.1 Genetron Health Details
9.8.2 Genetron Health Major Business
9.8.3 Genetron Health Blood-based Cancer Screening Tests Product and Services
9.8.4 Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Genetron Health Recent Developments/Updates
9.8.6 Genetron Health Competitive Strengths & Weaknesses
9.9 Singlera Genomics
9.9.1 Singlera Genomics Details
9.9.2 Singlera Genomics Major Business
9.9.3 Singlera Genomics Blood-based Cancer Screening Tests Product and Services
9.9.4 Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Singlera Genomics Recent Developments/Updates
9.9.6 Singlera Genomics Competitive Strengths & Weaknesses
9.10 Berry Oncology
9.10.1 Berry Oncology Details
9.10.2 Berry Oncology Major Business
9.10.3 Berry Oncology Blood-based Cancer Screening Tests Product and Services
9.10.4 Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Berry Oncology Recent Developments/Updates
9.10.6 Berry Oncology Competitive Strengths & Weaknesses
9.11 Helio Genomics
9.11.1 Helio Genomics Details
9.11.2 Helio Genomics Major Business
9.11.3 Helio Genomics Blood-based Cancer Screening Tests Product and Services
9.11.4 Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Helio Genomics Recent Developments/Updates
9.11.6 Helio Genomics Competitive Strengths & Weaknesses
9.12 Sysmex
9.12.1 Sysmex Details
9.12.2 Sysmex Major Business
9.12.3 Sysmex Blood-based Cancer Screening Tests Product and Services
9.12.4 Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sysmex Recent Developments/Updates
9.12.6 Sysmex Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Blood-based Cancer Screening Tests Industry Chain
10.2 Blood-based Cancer Screening Tests Upstream Analysis
10.3 Blood-based Cancer Screening Tests Midstream Analysis
10.4 Blood-based Cancer Screening Tests Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Blood-based Cancer Screening Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Blood-based Cancer Screening Tests Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Blood-based Cancer Screening Tests Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Blood-based Cancer Screening Tests Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Blood-based Cancer Screening Tests Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Blood-based Cancer Screening Tests Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Blood-based Cancer Screening Tests Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Blood-based Cancer Screening Tests Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Blood-based Cancer Screening Tests Players in 2025
Table 12. World Blood-based Cancer Screening Tests Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Blood-based Cancer Screening Tests Company Evaluation Quadrant
Table 14. Head Office of Key Blood-based Cancer Screening Tests Players
Table 15. Blood-based Cancer Screening Tests Market: Company Product Type Footprint
Table 16. Blood-based Cancer Screening Tests Market: Company Product Application Footprint
Table 17. Blood-based Cancer Screening Tests Mergers & Acquisitions Activity
Table 18. United States VS China Blood-based Cancer Screening Tests Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Blood-based Cancer Screening Tests Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Blood-based Cancer Screening Tests Companies, Headquarters (States, Country)
Table 21. United States Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Blood-based Cancer Screening Tests Revenue Market Share (2021-2026)
Table 23. China Based Blood-based Cancer Screening Tests Companies, Headquarters (Province, Country)
Table 24. China Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Blood-based Cancer Screening Tests Revenue Market Share (2021-2026)
Table 26. Rest of World Based Blood-based Cancer Screening Tests Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Blood-based Cancer Screening Tests Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Blood-based Cancer Screening Tests Revenue Market Share (2021-2026)
Table 29. World Blood-based Cancer Screening Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Blood-based Cancer Screening Tests Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Blood-based Cancer Screening Tests Market Size by Type (2027-2032) & (USD Million)
Table 32. World Blood-based Cancer Screening Tests Market Size by Biomarker, (USD Million), 2021 & 2025 & 2032
Table 33. World Blood-based Cancer Screening Tests Market Size Value by Biomarker (2021-2026) & (USD Million)
Table 34. World Blood-based Cancer Screening Tests Market Size by Biomarker (2027-2032) & (USD Million)
Table 35. World Blood-based Cancer Screening Tests Market Size by Test Format, (USD Million), 2021 & 2025 & 2032
Table 36. World Blood-based Cancer Screening Tests Market Size Value by Test Format (2021-2026) & (USD Million)
Table 37. World Blood-based Cancer Screening Tests Market Size by Test Format (2027-2032) & (USD Million)
Table 38. World Blood-based Cancer Screening Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & (USD Million)
Table 40. World Blood-based Cancer Screening Tests Market Size by Application (2027-2032) & (USD Million)
Table 41. GRAIL Basic Information, Manufacturing Base and Competitors
Table 42. GRAIL Major Business
Table 43. GRAIL Blood-based Cancer Screening Tests Product and Services
Table 44. GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GRAIL Recent Developments/Updates
Table 46. GRAIL Competitive Strengths & Weaknesses
Table 47. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 48. Guardant Health Major Business
Table 49. Guardant Health Blood-based Cancer Screening Tests Product and Services
Table 50. Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Guardant Health Recent Developments/Updates
Table 52. Guardant Health Competitive Strengths & Weaknesses
Table 53. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Exact Sciences Major Business
Table 55. Exact Sciences Blood-based Cancer Screening Tests Product and Services
Table 56. Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Exact Sciences Recent Developments/Updates
Table 58. Exact Sciences Competitive Strengths & Weaknesses
Table 59. Freenome Basic Information, Manufacturing Base and Competitors
Table 60. Freenome Major Business
Table 61. Freenome Blood-based Cancer Screening Tests Product and Services
Table 62. Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Freenome Recent Developments/Updates
Table 64. Freenome Competitive Strengths & Weaknesses
Table 65. Natera Basic Information, Manufacturing Base and Competitors
Table 66. Natera Major Business
Table 67. Natera Blood-based Cancer Screening Tests Product and Services
Table 68. Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Natera Recent Developments/Updates
Table 70. Natera Competitive Strengths & Weaknesses
Table 71. Foresight Diagnostics Basic Information, Manufacturing Base and Competitors
Table 72. Foresight Diagnostics Major Business
Table 73. Foresight Diagnostics Blood-based Cancer Screening Tests Product and Services
Table 74. Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Foresight Diagnostics Recent Developments/Updates
Table 76. Foresight Diagnostics Competitive Strengths & Weaknesses
Table 77. Burning Rock Biotech Basic Information, Manufacturing Base and Competitors
Table 78. Burning Rock Biotech Major Business
Table 79. Burning Rock Biotech Blood-based Cancer Screening Tests Product and Services
Table 80. Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Burning Rock Biotech Recent Developments/Updates
Table 82. Burning Rock Biotech Competitive Strengths & Weaknesses
Table 83. Genetron Health Basic Information, Manufacturing Base and Competitors
Table 84. Genetron Health Major Business
Table 85. Genetron Health Blood-based Cancer Screening Tests Product and Services
Table 86. Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Genetron Health Recent Developments/Updates
Table 88. Genetron Health Competitive Strengths & Weaknesses
Table 89. Singlera Genomics Basic Information, Manufacturing Base and Competitors
Table 90. Singlera Genomics Major Business
Table 91. Singlera Genomics Blood-based Cancer Screening Tests Product and Services
Table 92. Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Singlera Genomics Recent Developments/Updates
Table 94. Singlera Genomics Competitive Strengths & Weaknesses
Table 95. Berry Oncology Basic Information, Manufacturing Base and Competitors
Table 96. Berry Oncology Major Business
Table 97. Berry Oncology Blood-based Cancer Screening Tests Product and Services
Table 98. Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Berry Oncology Recent Developments/Updates
Table 100. Berry Oncology Competitive Strengths & Weaknesses
Table 101. Helio Genomics Basic Information, Manufacturing Base and Competitors
Table 102. Helio Genomics Major Business
Table 103. Helio Genomics Blood-based Cancer Screening Tests Product and Services
Table 104. Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Helio Genomics Recent Developments/Updates
Table 106. Helio Genomics Competitive Strengths & Weaknesses
Table 107. Sysmex Basic Information, Manufacturing Base and Competitors
Table 108. Sysmex Major Business
Table 109. Sysmex Blood-based Cancer Screening Tests Product and Services
Table 110. Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sysmex Recent Developments/Updates
Table 112. Sysmex Competitive Strengths & Weaknesses
Table 113. Global Key Players of Blood-based Cancer Screening Tests Upstream (Raw Materials)
Table 114. Global Blood-based Cancer Screening Tests Typical Customers
Table 1. World Blood-based Cancer Screening Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Blood-based Cancer Screening Tests Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Blood-based Cancer Screening Tests Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Blood-based Cancer Screening Tests Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Blood-based Cancer Screening Tests Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Blood-based Cancer Screening Tests Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Blood-based Cancer Screening Tests Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Blood-based Cancer Screening Tests Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Blood-based Cancer Screening Tests Players in 2025
Table 12. World Blood-based Cancer Screening Tests Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Blood-based Cancer Screening Tests Company Evaluation Quadrant
Table 14. Head Office of Key Blood-based Cancer Screening Tests Players
Table 15. Blood-based Cancer Screening Tests Market: Company Product Type Footprint
Table 16. Blood-based Cancer Screening Tests Market: Company Product Application Footprint
Table 17. Blood-based Cancer Screening Tests Mergers & Acquisitions Activity
Table 18. United States VS China Blood-based Cancer Screening Tests Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Blood-based Cancer Screening Tests Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Blood-based Cancer Screening Tests Companies, Headquarters (States, Country)
Table 21. United States Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Blood-based Cancer Screening Tests Revenue Market Share (2021-2026)
Table 23. China Based Blood-based Cancer Screening Tests Companies, Headquarters (Province, Country)
Table 24. China Based Companies Blood-based Cancer Screening Tests Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Blood-based Cancer Screening Tests Revenue Market Share (2021-2026)
Table 26. Rest of World Based Blood-based Cancer Screening Tests Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Blood-based Cancer Screening Tests Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Blood-based Cancer Screening Tests Revenue Market Share (2021-2026)
Table 29. World Blood-based Cancer Screening Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Blood-based Cancer Screening Tests Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Blood-based Cancer Screening Tests Market Size by Type (2027-2032) & (USD Million)
Table 32. World Blood-based Cancer Screening Tests Market Size by Biomarker, (USD Million), 2021 & 2025 & 2032
Table 33. World Blood-based Cancer Screening Tests Market Size Value by Biomarker (2021-2026) & (USD Million)
Table 34. World Blood-based Cancer Screening Tests Market Size by Biomarker (2027-2032) & (USD Million)
Table 35. World Blood-based Cancer Screening Tests Market Size by Test Format, (USD Million), 2021 & 2025 & 2032
Table 36. World Blood-based Cancer Screening Tests Market Size Value by Test Format (2021-2026) & (USD Million)
Table 37. World Blood-based Cancer Screening Tests Market Size by Test Format (2027-2032) & (USD Million)
Table 38. World Blood-based Cancer Screening Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & (USD Million)
Table 40. World Blood-based Cancer Screening Tests Market Size by Application (2027-2032) & (USD Million)
Table 41. GRAIL Basic Information, Manufacturing Base and Competitors
Table 42. GRAIL Major Business
Table 43. GRAIL Blood-based Cancer Screening Tests Product and Services
Table 44. GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GRAIL Recent Developments/Updates
Table 46. GRAIL Competitive Strengths & Weaknesses
Table 47. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 48. Guardant Health Major Business
Table 49. Guardant Health Blood-based Cancer Screening Tests Product and Services
Table 50. Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Guardant Health Recent Developments/Updates
Table 52. Guardant Health Competitive Strengths & Weaknesses
Table 53. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Exact Sciences Major Business
Table 55. Exact Sciences Blood-based Cancer Screening Tests Product and Services
Table 56. Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Exact Sciences Recent Developments/Updates
Table 58. Exact Sciences Competitive Strengths & Weaknesses
Table 59. Freenome Basic Information, Manufacturing Base and Competitors
Table 60. Freenome Major Business
Table 61. Freenome Blood-based Cancer Screening Tests Product and Services
Table 62. Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Freenome Recent Developments/Updates
Table 64. Freenome Competitive Strengths & Weaknesses
Table 65. Natera Basic Information, Manufacturing Base and Competitors
Table 66. Natera Major Business
Table 67. Natera Blood-based Cancer Screening Tests Product and Services
Table 68. Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Natera Recent Developments/Updates
Table 70. Natera Competitive Strengths & Weaknesses
Table 71. Foresight Diagnostics Basic Information, Manufacturing Base and Competitors
Table 72. Foresight Diagnostics Major Business
Table 73. Foresight Diagnostics Blood-based Cancer Screening Tests Product and Services
Table 74. Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Foresight Diagnostics Recent Developments/Updates
Table 76. Foresight Diagnostics Competitive Strengths & Weaknesses
Table 77. Burning Rock Biotech Basic Information, Manufacturing Base and Competitors
Table 78. Burning Rock Biotech Major Business
Table 79. Burning Rock Biotech Blood-based Cancer Screening Tests Product and Services
Table 80. Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Burning Rock Biotech Recent Developments/Updates
Table 82. Burning Rock Biotech Competitive Strengths & Weaknesses
Table 83. Genetron Health Basic Information, Manufacturing Base and Competitors
Table 84. Genetron Health Major Business
Table 85. Genetron Health Blood-based Cancer Screening Tests Product and Services
Table 86. Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Genetron Health Recent Developments/Updates
Table 88. Genetron Health Competitive Strengths & Weaknesses
Table 89. Singlera Genomics Basic Information, Manufacturing Base and Competitors
Table 90. Singlera Genomics Major Business
Table 91. Singlera Genomics Blood-based Cancer Screening Tests Product and Services
Table 92. Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Singlera Genomics Recent Developments/Updates
Table 94. Singlera Genomics Competitive Strengths & Weaknesses
Table 95. Berry Oncology Basic Information, Manufacturing Base and Competitors
Table 96. Berry Oncology Major Business
Table 97. Berry Oncology Blood-based Cancer Screening Tests Product and Services
Table 98. Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Berry Oncology Recent Developments/Updates
Table 100. Berry Oncology Competitive Strengths & Weaknesses
Table 101. Helio Genomics Basic Information, Manufacturing Base and Competitors
Table 102. Helio Genomics Major Business
Table 103. Helio Genomics Blood-based Cancer Screening Tests Product and Services
Table 104. Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Helio Genomics Recent Developments/Updates
Table 106. Helio Genomics Competitive Strengths & Weaknesses
Table 107. Sysmex Basic Information, Manufacturing Base and Competitors
Table 108. Sysmex Major Business
Table 109. Sysmex Blood-based Cancer Screening Tests Product and Services
Table 110. Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sysmex Recent Developments/Updates
Table 112. Sysmex Competitive Strengths & Weaknesses
Table 113. Global Key Players of Blood-based Cancer Screening Tests Upstream (Raw Materials)
Table 114. Global Blood-based Cancer Screening Tests Typical Customers
LIST OF FIGURES
Figure 1. Blood-based Cancer Screening Tests Picture
Figure 2. World Blood-based Cancer Screening Tests Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Blood-based Cancer Screening Tests Total Revenue (2021-2032) & (USD Million)
Figure 4. World Blood-based Cancer Screening Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Blood-based Cancer Screening Tests Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 13. Blood-based Cancer Screening Tests Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 16. World Blood-based Cancer Screening Tests Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 18. China Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 23. India Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Blood-based Cancer Screening Tests by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Blood-based Cancer Screening Tests Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Blood-based Cancer Screening Tests Markets in 2025
Figure 27. United States VS China: Blood-based Cancer Screening Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Blood-based Cancer Screening Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Blood-based Cancer Screening Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Blood-based Cancer Screening Tests Market Size Market Share by Type in 2025
Figure 31. Single-cancer Screening
Figure 32. Multi-cancer Early Detection
Figure 33. Colorectal Cancer Screening
Figure 34. Liver Cancer Screening
Figure 35. Lung Cancer Screening
Figure 36. Risk Stratification Test
Figure 37. Other
Figure 38. Other
Figure 39. World Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2032)
Figure 40. World Blood-based Cancer Screening Tests Market Size by Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 41. World Blood-based Cancer Screening Tests Market Size Market Share by Biomarker in 2025
Figure 42. cfDNA Methylation
Figure 43. ctDNA Mutation
Figure 44. Fragmentomics
Figure 45. Protein Biomarkers
Figure 46. Multi-omics
Figure 47. Exosome-based
Figure 48. Other
Figure 49. Other
Figure 50. World Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2021-2032)
Figure 51. World Blood-based Cancer Screening Tests Market Size by Test Format, (USD Million), 2021 & 2025 & 2032
Figure 52. World Blood-based Cancer Screening Tests Market Size Market Share by Test Format in 2025
Figure 53. Laboratory-developed Test
Figure 54. IVD Kit
Figure 55. Sequencing-based
Figure 56. PCR-based
Figure 57. Immunoassay-based
Figure 58. Other
Figure 59. World Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2021-2032)
Figure 60. World Blood-based Cancer Screening Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Blood-based Cancer Screening Tests Market Size Market Share by Application in 2025
Figure 62. Health Check-up Centers
Figure 63. Hospitals
Figure 64. Independent Clinical Laboratories
Figure 65. Other
Figure 66. World Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2032)
Figure 67. Blood-based Cancer Screening Tests Industrial Chain
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Blood-based Cancer Screening Tests Picture
Figure 2. World Blood-based Cancer Screening Tests Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Blood-based Cancer Screening Tests Total Revenue (2021-2032) & (USD Million)
Figure 4. World Blood-based Cancer Screening Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Blood-based Cancer Screening Tests Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Blood-based Cancer Screening Tests Revenue (2021-2032) & (USD Million)
Figure 13. Blood-based Cancer Screening Tests Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 16. World Blood-based Cancer Screening Tests Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 18. China Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 23. India Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Blood-based Cancer Screening Tests by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Blood-based Cancer Screening Tests Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Blood-based Cancer Screening Tests Markets in 2025
Figure 27. United States VS China: Blood-based Cancer Screening Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Blood-based Cancer Screening Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Blood-based Cancer Screening Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Blood-based Cancer Screening Tests Market Size Market Share by Type in 2025
Figure 31. Single-cancer Screening
Figure 32. Multi-cancer Early Detection
Figure 33. Colorectal Cancer Screening
Figure 34. Liver Cancer Screening
Figure 35. Lung Cancer Screening
Figure 36. Risk Stratification Test
Figure 37. Other
Figure 38. Other
Figure 39. World Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2032)
Figure 40. World Blood-based Cancer Screening Tests Market Size by Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 41. World Blood-based Cancer Screening Tests Market Size Market Share by Biomarker in 2025
Figure 42. cfDNA Methylation
Figure 43. ctDNA Mutation
Figure 44. Fragmentomics
Figure 45. Protein Biomarkers
Figure 46. Multi-omics
Figure 47. Exosome-based
Figure 48. Other
Figure 49. Other
Figure 50. World Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2021-2032)
Figure 51. World Blood-based Cancer Screening Tests Market Size by Test Format, (USD Million), 2021 & 2025 & 2032
Figure 52. World Blood-based Cancer Screening Tests Market Size Market Share by Test Format in 2025
Figure 53. Laboratory-developed Test
Figure 54. IVD Kit
Figure 55. Sequencing-based
Figure 56. PCR-based
Figure 57. Immunoassay-based
Figure 58. Other
Figure 59. World Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2021-2032)
Figure 60. World Blood-based Cancer Screening Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Blood-based Cancer Screening Tests Market Size Market Share by Application in 2025
Figure 62. Health Check-up Centers
Figure 63. Hospitals
Figure 64. Independent Clinical Laboratories
Figure 65. Other
Figure 66. World Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2032)
Figure 67. Blood-based Cancer Screening Tests Industrial Chain
Figure 68. Methodology
Figure 69. Research Process and Data Source
